SMTL ID : 5cmu.1

Artificial HIV fusion inhibitor AP1 fused to the C-terminus of gp41 NHR

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

homo-trimer

Ligands

5 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 6 residues within 4Å: Chain A: G.43, E.46, W.47, E.50 Chain C: L.24, W.27 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.43 GOL.2: 7 residues within 4Å: Chain B: G.40, R.41, G.42, G.43, W.44, M.45, E.46 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:R.41, B:G.43, B:W.44, B:M.45, B:E.46, B:E.46 GOL.3: 6 residues within 4Å: Chain B: Q.31, R.35 Chain C: L.37, R.41, G.42, W.44 4 PLIP interactions: 2 interactions with chain C, 2 interactions with chain B Hydrogen bonds: C:R.41, C:G.42, B:R.35, B:R.35 GOL.4: 3 residues within 4Å: Chain C: K.63, K.64, E.67 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:E.67 GOL.5: 4 residues within 4Å: Chain C: K.30, Q.33, A.34, D.48 5 PLIP interactions: 5 interactions with chain C Hydrogen bonds: C:K.30, C:D.48 Water bridges: C:Q.33, C:A.34, C:S.38

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, X. et al., Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy. Sci Rep (2015)

Release Date

2015-09-16

Peptides

Envelope glycoprotein,AP1: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Envelope glycoprotein,AP1